Nike, the renowned sportswear company, has announced better-than-anticipated first-quarter profit. By successfully selling off a portion of its stock and reducing inventory by 10% compared to the previous year, Nike proved its financial prowess. Consequently, shares have surged by an impressive 7.6% to reach $96.45 after-hours.
Novo Integrated Sciences Announces $1 Billion Collateral Transfer Deal
With the successful conclusion of a significant master collateral transfer deal worth $1 billion, Novo Integrated Sciences has declared that its capital requirements for the next 15 years are duly met. CEO Robert Mattacchione expressed his enthusiasm for this development, as it will enable the healthcare company to actively pursue its international growth ambitions. The market responded favorably to this announcement, as shares more than doubled to a commendable 43 cents.
PTC Therapeutics Implements Workforce Reductions
PTC Therapeutics, as part of its ongoing cost-reduction efforts, has made the decision to trim its workforce by 25%. This strategic move follows a previous announcement in May regarding an 8% reduction in employees. However, with further workforce reductions now in effect, the company anticipates significant annual savings of 20% in operating expenses. Consequently, shares have experienced a notable increase of 4.8% to reach $23.74 after-hours.
